Showing results (1651-1660 of 1,676) with videos related to

Sort By:
Pageof 168
Cancer Research|January 1, 1997
Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugatesP A Trail, D Willner, J Knipe, et al.
Nature Communications|July 31, 2025
GFP-on mouse model for interrogation of in vivo gene editingCarla Dib, Jack A Queenan, Leah Swartzrock, et al.
Annals of Neurology|June 3, 2010
Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophyVinod Malik, Louise R Rodino-Klapac, Laurence Viollet, et al.
Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science|December 11, 2013
Comprehensive laboratory evaluation of a highly specific lateral flow assay for the presumptive identification of ricin in suspicious white powders and environmental samplesDavid R Hodge, Kristin Willner Prentice, Jason G Ramage, et al.
Prenatal Diagnosis|January 5, 2023
Turner syndrome-omphalocele association: Incidence, karyotype, phenotype and fetal outcomeIvonne Bedei, Karl-Philipp Gloning, Luc Joyeux, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 1, 2021
Improving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume doseL Wilke, C Moustakis, O Blanck, et al.
Journal of Clinical Medicine|August 12, 2022
Is Fetal Hydrops in Turner Syndrome a Risk Factor for the Development of Maternal Mirror Syndrome?Ivonne Alexandra Bedei, Alexander Graf, Karl-Philipp Gloning, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
Delta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasmsRohit Thummalapalli, Salomon Tendler, Joanne F Chou, et al.
JCO Precision Oncology|November 20, 2025
Delta-Like Ligand 3 Expression and Functional Imaging in Gastroenteropancreatic Neuroendocrine NeoplasmsRohit Thummalapalli, Salomon Tendler, Joanne F Chou, et al.
Radiation Oncology (London, England)|May 20, 2026
Outcome of patients with lung cancer treated with stereotactic body radiotherapy for bone oligometastases - a European multicenter cohort studySebastian Schäfer, Isabell Seiler, Panagiotis Balermpas, et al.
Pageof 168